Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan

Title
Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan
Authors
Keywords
-
Journal
RESPIRATORY MEDICINE
Volume 141, Issue -, Pages 56-63
Publisher
Elsevier BV
Online
2018-06-28
DOI
10.1016/j.rmed.2018.06.021

Ask authors/readers for more resources

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now